Latest round: IPO. Frank Oakes was the President and Chief Executive Officer of Stellar Biotechnologies, Inc. Based in Port Hueneme, United States.
Frank Oakes was the President and Chief Executive Officer of Stellar Biotechnologies, Inc. The company, based north of Los Angeles at the Port of Hueneme, was a leading manufacturer of Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein used in therapeutic vaccine pipelines. In 2019, Stellar Biotechnologies executed a share exchange agreement with Edesa Biotech Inc., a Canadian company, which was expected to result in a change of control and the renaming of Stellar to Edesa Biotech Inc.
Full founder directory · Investor directory · Company funding database · Fundraising library